Continuous renal replacement therapy in patients following traumatic injury

International Journal of Artificial Organs

Volumn 29, Issue 2, 2006, Pages 166-186

  McCunn, Maureen ^a   Reynolds, H N ^a   Reuter, J ^b   McQuillan, K ^a   McCourt, T ^a   Stein, D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

CRRT; CRRT education; CRRT safety; CRRT training; Injury; Renal replacement therapy; Rhabdomyolysis; Trauma

Indexed keywords

CRRT; CRRT EDUCATION; CRRT SAFETY; CRRT TRAINING; INJURY; RENAL REPLACEMENT THERAPIES; RHABDOMYOLYSE; TRAUMA; TRAUMA PATIENTS; TRAUMATIC INJURY;

PATIENT REHABILITATION;

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ARGATROBAN; BENZODIAZEPINE DERIVATIVE; CALCIUM CHLORIDE; CITRATE TRISODIUM; DIALYSIS FLUID; DIGOXIN; GENTAMICIN; HEPARIN; HIRUDIN; MANNITOL; NAFAMSTAT MESILATE; NARCOTIC AGENT; OXYGEN; PLASMA LYTE; PROPOFOL; PROSTACYCLIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ACUTE KIDNEY FAILURE; ANTICOAGULANT THERAPY; BLEEDING; BLEEDING DISORDER; BRAIN INJURY; CLINICAL PRACTICE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICAL ILLNESS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG METABOLISM; HEART FAILURE; HEMODIALYSIS; HEMOFILTRATION; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HUMAN; HYPERBARIC OXYGEN; HYPERNATREMIA; HYPOCALCEMIA; HYPOTENSION; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY FUNCTION; META ANALYSIS; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; MORTALITY; NECROTIZING AND SOFT TISSUE INFECTION; NONHUMAN; NUTRITIONAL STATUS; ORGAN INJURY; PROPOFOL INFUSION SYNDROME; REVIEW; RHABDOMYOLYSIS; SEPSIS; SOFT TISSUE DISEASE; STAFF TRAINING; SURVIVAL RATE; TRAUMATOLOGY; TREATMENT INDICATION; ULTRAFILTRATION; UNITED STATES;

EID: 33645802369     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880602900204     Document Type: Review

References (166)

1. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: A cohort analysis. JAMA 1996; 275: 1489-94.
2. Hamel MB, Phillips RS, Davis RB, Desbiens N, Connors AF, Teno JM, et al. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. Ann Intern Med 1997; 127: 195-202.
3. McCarthy JT. Prognosis of patients with acute renal failure in the intensive care unit: A tale of two eras. Mayo Clin Proc 1996; 71: 117-26.
4. Nolan CR, Anderson RJ. Hospital-acquired acute renal failure. J Am Soc Nephrol 1998; 9: 710-8.
5. Morris JA Jr, Mucha P Jr, Ross SE, et al. Acute post-traumatic renal failure: A multi-center perspective. J Trauma 1991; 31: 1584-90.
6. Regel G, Lobenhoffer P, Grotz M, Pape HC, Lahmann, Trscherne H. Treatment results of patients with multiple trauma: An analysis of 3406 cases treated between 1972 and 1991 at German Level I Trauma Center. J Trauma 1995; 38: 70-7.
7. Vivino G, Antonelli M, Moro ML, Cottini G, Conti G, Bufi M, Cannata F, Gasparetto A. Risk factors for acute renal failure in trauma patients. Intensive Care Med 1998; 24: 808-14.
8. Bellomo R, Kellum J, Ronco C. Acute renal failure: Time for consensus. Intensive Care Med 2001; 27: 1685-8.
9. Brivet FG, Kleinknecht DJ, Loirat P, et al. Acute renal failure in intensive care units. Causes, outcome, and prognostic factors of hospital mortality; a prospective, multi-centre study. Crit Care Med 1996; 24: 192-8.
10. Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 2001; 29: 1910-5.
11. McCunn M, McCourt T, McQuillan K, Habashi N, Adams K, Andrews P, et al. Implementation of a multi-disciplinary continuous renal replacement therapy service: Process and progress. Crit Care Med 2002; 30: A151.
12. Cole L, Bellomo R, Silvester W, Reeves JH. A Prospective, multi-center study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. Am J Respir Crit Care Med 2000; 162: 191-6.
13. Charytan C, Kaplan AA, Paganini E, Weiss J, Owen WF. Role of the Nephrologist in the Intensive Care Unit. Am J Kidney Dis 2001: 38: 426-9.
14. Mehta RL. Acute renal failure in the intensive care unit: Which outcomes should we measure? Am J Kidney Dis 1996; 28 (suppl): S74.
15. Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: A randomized controlled study. Am J Kidney Dis 2004; 43: 342-9.
16. Briglia A. Economics of SLED versus CRRT at the University of Maryland Medical Systems (unpublished data).
17. Better OS. History of the crush syndrome. From the earthquake of Messina, Sicily 1909 to Spitak, Armenia, 1988. Am J Nephrol 1997; 17: 392-4.
18. Frankerthal L. Uber Verschttunge. Virchows Arch 1916: 222-32.
19. Bywaters EG, Beall D. Crush injuries with impairment of renal function. Br Med J 1941; 1: 427-32.
20. Smith LH, Post RS, Teschan PE, et al. Post-traumatic renal insufficiency in military casualties: Clinical characteristics. Am J Med 1955; 18: 187-98.
21. Swann RC, Merrill JP. The clinical course of acute renal failure. Medicine (Baltimore) 1953; 32: 215-92.
22. Fischer RP. High mortality of post-traumatic renal insufficiency in Vietnam: A review of 96 cases. Am Surg 1974: 40: 172-7.
23. Anderson RJ, Linas SL, Berns AS, Henrich WL, Miller TR, Gabow PA, Schrier RW. Nonoliguric acute renal failure. N Engl J Med 1977; 296: 134-8.
24. Schroeder TH, Hansen M, Dinkelaker K, Krueger WA, Nohe B, Fretschner R, Unertl K. Influence of underlying disease on the outcome of critically ill patients with acute renal failure. Eur J Anaesthesiol 2004; 21: 848-53.
25. Gettings LG, Reynolds HN, Scalea T. Outcome of post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med 1999; 25: 805-13.
26. Mullins R. A Historical Perspective of Trauma System Development in the United States. J Trauma 1999; 47 (suppl): S8-14.
27. Welch PG. Deployment dialysis in the U.S. Army: History and future challenges. Mil Med 2000; 165: 737-41.
28. Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomolysis. Intensive Care Med 2001; 27: 803-11.
29. Ostric V, Radovic M, Stanojevic P, Djukanovic L. Acute renal failure in polytraumatized patients: prediction of outcome. Ren Fail 1996; 18: 607-13.
30. D'Elia JA, Gleason RE, Alday M, et al. Nephrotoxicity from angiographic contrast material: A prospective study. Am J Med 1982; 72: 719-25.
31. Stene JK. Renal failure in the trauma patient. Crit Care Clin 1990; 6: 111-9.
32. Chrysopoulo MT, Jeschke MG, Dziewulski P, Barrow RE, Herndon DN. Acute renal dysfunction in severely burned adults. J Trauma 1999; 46: 141-4.
33. Prall JA, Breeze RE. Rhabdomyolysis following spinal cord injury: Case report. J Trauma 1995; 39: 802-4.
34. Knottenbelt JD. Traumatic rhabdomyolysis from severe beating - experience of volume diuresis in 200 patients. J Trauma 1994; 37: 214-9.
35. Bloom AI, Zamir G, Muggia M, Friedlaender M, Gammon Z, Rivkind A. Torture rhabdomyolysis - a pseudo-crush syndrome. J Trauma 1995; 38: 252-4.
36. Smith CD, Moir CR, Mucha P Jr. Rhabdomyolysis and renal failure following a wolf attack: Case report. J Trauma 1991; 31: 423-5.
37. Sandhu RS, Como JJ, Scalea TS. Renal failure and exercise-induced rhabdomyolysis in patients taking performance-enhancing compounds. J Trauma 2002; 53: 761-4.
38. Brown CV, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC. Preventing renal failure in patients with rhabdomyolysis: Do bicarbonate and mannitol make a difference? J Trauma 2004; 56: 1191-6.
39. Antonelli M, Moro ML, Vivino G. Bacteremia, pneumonia and acute renal failure in trauma patients. In: Yearbook of Intensive Care Emerg Med. Berlin: Springer Verlag; 1995. p 834-42.
40. Ivatury RR, Sugerman HJ, Peitzman AB. Abdominal compartment syndrome: Recognition and management. Adv Surg 2001; 35: 251-69.
41. Shinozaki M. Hemodynamic relationship between renal venous pressure during positive and expiratory pressure. Crit Care Med 1988; 16: 144-7.
42. Journois D, Silvester W. Continuous hemofiltration in patients with sepsis or multiorgan failure. Semin Dial 1996; 9: 173-8.
43. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351: 159-69.
44. Abraham E, Andrews P, Antonelli M, Brochard L, Brun-Buisson C, Dobb G, Fagon JY, Groeneveld J, Mancebo J, Metnitz P, Nava S, Pinsky M, Radermacher P, Ranieri M, Richard C, Tasker R, Vallet B. Year in review in intensive care medicine: 2003. II. Brain injury, hemodynamics, gastrointestinal tract, renal failure, metabolism, trauma, and postoperative. Intensive Care Med 2004; 30: 1266-75.
45. Osborn TM, Tracy JK, Dunne JR, Pasquale M, Napolitano L. Epidemiology of sepsis in patients with traumatic injury. Crit Care Med 2004; 32: 2234-40.
46. Waydhas C, Dieter NK, Trupka A, Zettl R, Kich M, Wiesholler J, et al. Post-traumatic inflammatory response, secondary operations, and late multiple organ failure. J Trauma 1996; 40: 624-31.
47. Pape HC, Griensven M, Rice J, Gänsslen A, Hildebrand F, Zech S, et al. Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: Determination of the clinical relevance of biochemical markers. J Trauma 1996; 50: 989-1000.
48. Shimazu T, Yoshioda T, Nakata Y, et al. Fluid resuscitation and systemic complications in crush syndrome of 14 Hanshin-Awaji earthquake patients. J Trauma 1997; 42: 641-6.
49. Homsi E, Fernanda M, Barreiro L, et al. Prophylaxsis of acute renal failure in patients with rhabdomyolysis. Ren Fail 1997; 19: 283-8.
50. Feinfeld DA, Cheng JT, Beysolow TD, Briscoe AM. A prospective study of urine and serum myoglobin levels in patients with acute rhabdomyolysis. Clin Nephrol 1992; 38: 193-5.
51. Lappalainen H, Tiula E, Uotila L, Manttari M. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: Implications and follow-up. Crit Care Med 2002; 30: 2212-5.
52. Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 1988; 148: 1553-7.
53. Oda J, Tanaka H, Yoshioka T, et al. Analysis of 372 patients with crush syndrome caused by the Hanshin-Awaji earthquake. J Trauma 1997; 42: 470-6.
54. Ayer G, Grandchamp A. Wyler T, et al. Intrarenal hemodynamics in glycerol-induced myohemoglobinuric acute renal failure in the rat. Circ Res 1971; 24: 128-32.
55. Oken DE, DiBona GF, McDonald FD. Micropuncture studies of the recovery phase of myohemoglobinuric acute renal failure in the rat. J Clin Invest 1970; 49: 730-5.
56. Zager R. Studies of mechanism and protective maneuvers in myoglobinuric acute renal failure. Lab Invest 1989; 60: 619-29.
57. Slater M, Mullins R. Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: A review. J Am Coll Surg 1998; 186: 693-716.
58. Zager RA, Foerder C, Bredl C. The influence of mannitol on myoglobinuric acute renal failure: Functional, biochemical, and morphological assessments. J Am Soc Nephrol 1991; 2: 848-55.
59. Brown CVR, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC. Preventing renal failure in patients with rhabdomyolysis: Do bicarbonate and mannitol make a difference? J Trauma 2004; 56: 1191-6.
60. Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J. Lactate clearance and survival following injury. J Trauma 1993 35: 584-8.
61. Tremblay LN, Feliciano DV, Rozycki GS. Assessment of initial base deficit as a predictor of outcome: Mechanism of injury does make a difference. Am Surg 2002; 68: 689-93.
62. 2 saturation during resuscitation of traumatic shock monitored using near infrared spectrometry. J Trauma 2000; 48: 637-42.
63. Weil, McMaster P, Shann F. The use of extracorporeal techniques to remove humoral factors in sepsis. Pediatr Crit Care Med 2003: 4: 2-7.
64. Berns JS, Cohen RM, Rudnick MR. Removal of myoglobin by CAVH-D in traumatic rhabdomyolysis. Am J Nephrol 1991; 11: 73.
65. Polderman KH. Acute renal failure and rhabdomyolysis. Int J Artif Organs 2004; 27: 1030-3.
66. Amyot SL, Leblanc M, Thibeault Y, Geadah D, Cardinal J. Myoglobin clearance and removal during continuous venovenous hemofiltration. Intensive Care Med 1999; 25: 1169-72.
67. Nicolau D, Feng YS, Wu AHB, et al. Myoglobin clearance during continuous veno-venous hemofiltration with or without dialysis. Int J Artif Organs 1998; 21: 205-9.
68. Knochel JP. Mechanism of rhabdomyolysis. Curr Opin Rheumatol 1993; 5: 725-31.
69. Bastani B, Frenchie D. Significant myoglobin removal during continuous veno-venous hemodiafiltration using F8-membrane. Nephrol Dial Transplant 1997; 12: 2035-6.
70. Bellomo R Daskalakis M, Parkin G, Boyce N. Myoglobin clearance during acute continuous hemodiafiltration. Intensive Care Med 1991; 17: 509.
71. Schenk MR, Beck DH, Nolte M, Kox WJ. Continuous venovenous hemofiltration for the immediate management of massive rhabdomyolysis after fulminant malignant hyperthermia in a bodybuilder. Anesthesiology 2001; 94: 1139-41.
72. Splendiani G, Mazzarell V, Cipriani S, Pollicita S, Rodio F, Casciani C: Dialytic treatment for rhabdomyolysis-induced acute renal failure: our experience. Ren Fail 2001; 23: 183-91.
73. Oda Y, Shindoh M, Yukioka H, et al. Crush syndrome sustained in the 1995 Kobe, Japan earthquake; treatment and outcome. Ann Emerg Med 1997; 30: 507-12.
74. Mehta RL, McDonald B, Gabbai FB, et al. A randomized clinical trail of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60: 1154-63.
75. Swartz RD, Messana JM, Orzol S, Port FK. Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. Am J Kidney Dis 1999; 34: 424-32.
76. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure n the intensive care unit: A systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002; 40: 875-85.
77. Ronco C, Bellomo R, Homel P, et al. Effects of different does of continuous venovenous haemofiltration on outcomes of acute renal failure: A prospective randomized trial. Lancet 2000; 356: 26-30.
78. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305-10.
79. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002; 28: 29-37.
80. Uchino S, Bellomo R, Ronco C. Intermittent versus continuous renal replacement therapy in the ICU: Impact on electrolyte and acid-base balance. Intensive Care Med 2001; 27: 1037-43.
81. Frankenfeld DC, Wiles CE, Bagley SM, Siegel JH. Resting and total energy expenditure in trauma and septic patients. Crit Care Med 1994; 22: 1796-804.
82. Schrier RW, Henderson HS, Tischer CC, Tannen RL. Nephropathy associated with heat stress and exercise. Ann Intern Med 1976; 67: 356-76.
83. Wilmore DW. Metabolic response to severe surgical illness: Overview. World J Surg 2000; 24: 705-11.
84. Reid CL. Nutritional requirements of surgical and critically ill patients: Do we really know what they need? Proc Nutr Soc 2004; 63: 467-72.
85. Frankenfeld DC, Reynolds HN, Wiles CE, Badellino MM, Siegal JH. Urea removal during continuous hemodiafiltration. Crit Care Med 1994; 22: 407-12.
86. Reynolds HN, Borg U, Belzberg H, Wiles CE. Efficacy of continuous arteriovenous hemofiltration with dialysis in patients with renal failure. Crit Care Med 1991; 19: 1387-94.
87. Bartlett RH, Mault JR, Dechert RE, et al. Continuous arteriovenous hemofiltration: Improved survival in surgical acute renal failure? Surgery 1986; 100: 400-8.
88. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT. Epidemiology of trauma deaths: A reassessment. J Trauma 1995; 38: 185-93.
89. Hoyt DB, Bulger EM, Knudson MM, Morris J, Ierardi R, Sugerman HJ, Shackford SR, Landercasper J, Winchell RJ, Jurkovich G, et al. Death in the operating room: An analysis of a multi-center experience. J Trauma. 1994; 37: 426-32.
90. McKenzie EJ, Siegel JH, Shapiro S, et al. Functional recovery and medical cost of trauma: An analysis by type and severity of injury. J Trauma 1998; 28: 281-97.
91. Lazio BE, Simard JM. Anticoagulation in neurosurgical patients. Neurosurgery 1999; 45: 838-47.
92. Reynolds HN, Cottingham CA, McCunn M, Habashi NM, Scalea TS. Extracorporeal lung support in a patient with traumatic brain injury: the benefit of heparin-bonded circuitry. Perfusion 1999; 14: 489-93.
93. Chestnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993; 34: 216-22.
94. Davenport A. Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis 2001; 37: 457-66.
95. Winney RJ, Kean DM, Best JJ, Smith MA. Changes in brain water with hemodialysis. Lancet 1986; 2: 16-8.
96. Ronco C, Bellomo R, Brendolan A, Pinna V, LaGreca G. Brain density changes during renal replacement in critically ill patients with acute renal failure. J Nephrol 1999; 12: 173-8.
97. Bertrand YM, Hermant A, Mahieu P, Roeb J. Intracranial pressure changes in patients with head trauma during hemodialysis. Intensive Care Med 1883; 9: 321-3.
98. Silk DB, Trewby PN, Chase RA, Mellon PJ, Hanid MA, Davies M, et al. Treatment of fulminant hepatic failure polyacrylnitrile membrane hemodialysis. Lancet 1977: 2: 1-3.
99. Rosen SM, O'Connor K, Shaldon S. Hemodialysis disequilibrium syndrome. BMJ 1964; 2: 672-5.
100. Arieff AI. Dialysis disequilibrium syndrome: Current concepts on pathogenesis and prevention. Kidney Int 1994; 45: 629-35.
101. Davenport A, Will EJ, Losowsky MS, Swindells S. Continuous arteriovenous hemofiltration in patients with hepatic encephalopathy and renal failure. BMJ 1987; 295: 1028.
102. Davenport A. Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis 2001; 37: 457-66.
103. Doi K, Ogawa N, Suzuki E, Noiri E, Fujita T. Mannitol-induced acute renal failure. Am J Med 2003; 115: 593-4.
104. Viweswaran P, Massain EK, Dubose TD. Mannitol-induced acute renal failure. J Am Soc Nephrol 1997; 8: 1028-33.
105. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore) 1990; 69: 153-9.
106. American Association of Neurological Surgeons, Brain Trauma Foundation, Joint Section on Neurotrauma and Critical Care. Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2000; 17: 451-627.
107. Knudson MM. Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma 1996; 41: 446-59.
108. Tan HK, Baldwin I, Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patents. Intensive Care Med 2000; 26: 1652-7.
109. Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983; 308: 258-61.
110. Palsson R, Niles JL. Regional citrate anticoagulation in continuous veno-venous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999; 55: 1991-7.
111. Kelleher SP, Schulman G. Severe metabolic alkalosis complicating regional citrate hemodialysis. Am J Kidney Dis 1987; 9: 235-6.
112. Dutton RP, McCunn M, Hyder M, Angelo M, Connor J, Hess JR, et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004; 57: 709-19.
113. Gillum DM, Dixon BS, Yanover MJ, et al. The role of intensive dialysis in acute renal failure. Clin Nephrol 1986; 25: 249-55.
114. Cosentino F, Chaff C, Piedmonte M. Risk factors influencing survival in ICU acute renal failure. Nephrol Dial Transplant 1994; 9: 179-82.
115. Chertow GM, Christiansen CL, Cleary PD, et al. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 1995; 155: 1505-11.
116. Bohler J, Donauer J, Keller F. Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage. Kidney Int Suppl 1999; 72: S24-8.
117. Subach RA, Marx MA. Drug dosing in acute renal failure: The role of renal replacement therapy in altering drug pharmacokinetics. Adv Ren Replace Ther 1998; 5: 141-7.
118. Cointault O, Kamar N, Bories P, Lavayssiere L, Angles O, Rostaing L, et al. Regional citrate anticoagulation in continuous venovenous haemodia-filtration using commercial solutions. Nephrol Dial Transplant 2004; 19: 171-8.
119. Monchi M, Berghmas D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 2004; 30: 260-5.
120. Kutsogiannis KJ. Postfilter ionized calcium as a method for monitoring regional citrate anticoagulation in continuous venovenous haemodiafiltration (abstract). Blood Purif 1999; 17; 12.
121. Maxvold NJ, Bunchman TE. Renal failure and renal replacement therapy. Critical Care Clinics 2003; 19: 563-75.
122. Meyer MM. Renal replacement therapies. Crit Care Clin 2000; 16: 29-58.
123. Swartz RD, Flamenbaum W, Dubrow A, et al. Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: Preventing further bleeding complications. J Clin Pharmacol 1988; 28: 818-25.
124. Reetze-Bonorden P, Bohler J, Keller E. Drug dosage in patients during continuous renal replacement therapy: Pharmacokinetic and therapeutic considerations. Clin Pharmacokinet 1993; 24: 362-79.
125. Golper TA, Marx MA. Drug dosing adjustments during continuous renal replacement therapies. Kidney Int 1998; 53 (suppl 66): S165-8.
126. Joy MS, Matzke GR, Armstrong DK, Marx MA, Zarowitz. A primer on continuous renal replacement therapy for critically ill patients. Ann Pharmacother 1998; 32: 362-75.
127. Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P. Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med 1995; 21: 612-20.
128. Bressolle F, Kinowski JM, de la Coussaye JE, Wynn N, Eledjam JJ, Galtier M. Clinical pharmacokinetics during continuous haemofiltration. Clin Pharmacokinet 1994; 26: 457-71.
129. Teschan PE, Baxter CR, OBrien TF, et al. Prophylactic hemodialysis in the treatment of acute renal failure. Ann Intern Med 1960; 53: 992-1016.
130. Easterling RE, Forland M. A five year experience with prophylactic dialysis for acute renal failure. Trans Am Soc Artif Intern Organs 1964; 10: 200-8.
131. Parsons FM, Hobson SM, Blagg CR, et al. Optimum time for dialysis in acute reversible renal failure. Lancet 1961; 1: 129-34.
132. Bosteels V, Verberckmoes R, Vandenbroucke J, et al. Prognosis of acute renal insufficiency. In: Gessler U, Schröder K, Weidinger H, eds. Pathogenesis and clinical findings with renal failure, Symposium der Medizinischen Klinik. Stuttgart: Thiemem; 1969. p 234-6.
133. Kleinknecht D, Junders P Chanard J, et al. Factors influencing immediate prognosis in acute renal failure, with special reference to prophylactic hemodialysis. Adv Nephrol Necker Hosp 1971; 1: 207-30.
134. Conger JD. A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma 1975; 15: 1056-63.
135. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, et al. The prevention of radio-contrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333-40.
136. Hoffman JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D. Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 1996; 22: 1360-7.
137. Tetta C, Bellomo R, Ronco C. Artificial organ treatment for multiple organ failure, acute renal failure, and sepsis: Recent new trends. Artif Organs 2003; 27: 202-13.
138. Silvester W. Mediator removal with CRRT: Complement and cytokines. Am J Kidney Dis 1997; 30 (suppl): S38-43.
139. Sanchez-Izquierdo JA, Perez Vela JL, Lozano Quintana MJ, Alted Lopez E, Ortuno de Solo B, Ambros Checa A. Cytokines clearance during venovenous hemofiltration in the trauma patient. Am J Kidney Dis 1997; 30: 483-8.
140. Van Bommel EF. Should continuous renal replacement therapy be used for "non-renal" indications in critically ill patients with shock? Resuscitation 1997; 33: 257-70.
141. Koperna T, Vogl SE, Pöschl GP, Hamilton G, Röder G, Germann P. Cytokine patterns in patients who undergo hemofiltration for treatment of multiple organ failure. World J Surg 1998; 22: 443-8.
142. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s - systemic inflammatory response and organ dysfunction. JAMA 1994; 271: 226-33.
143. Yagi N, Leblance M, Sakai K, Wright EJ, Paganini EP. Cooling effect of continuous renal replacement therapy in critically ill patients. Am J Kidney Dis 1998; 32: 1023-30.
144. Matamis D, Tsagourias M, Koletsos K, Riggos k Mavromatidis K, Sombolos K, et al. Influence of continuous haemofiltration-related hypothermia on haemodynamic variables and gas exchange in septic patients. Intensive Care Med 1994; 20: 431-6.
145. Heering P, Morgera A, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997; 23: 288-96.
146. Mohr M, Hopken U, Oppermann M, Matzhes C, Goldmann K, Lerver S, et al. Effects of anti-C5a monoclonal antibodies on oxygen use in a porcine model of severe sepsis. Eur J Clin Invest 1998; 28: 227-34.
147. Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS. Propofol-associated rhabdomyolysis with cardiac involvement in adults: Chemical and anatomic findings. Clin Chem 2000; 46: 577-81.
148. Friedman JA, Manno E, Fulgham JR. Propofol. J Neurosurg 2002; 96: 1161-2.
149. Cremer OL, Moons KG, Bouman EA, Kruimiswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001; 357: 117-8.
150. Kelly DF. Propofol infusions syndrome. J Neurosurg 2001; 95: 925-6.
151. Vasile B, Rasula F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: A simple name for a complex syndrome. Intensive Care Med 2003; 29: 1417-25.
152. Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders. In: Scriver CD, Beaudet AL, Sly WS, Valle E, eds. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 1995. p 1501-33.
153. Branca D, Roberti MS, Lorenzin P, Vinccenti E, Scutari G. Influence of the anaesthetic 2,6, diisopropylphenol on toxidative phosphorylation of isolated rat liver mitochondria. Biochem Pharmacol 1991; 42: 87-90.
154. Tillou A, St Hill CR, Brown C, Velmahos G. Necrotizing soft tissue infections: improved outcomes with modern care. Am Surg 2004; 70: 841-4.
155. DiNubile MJ, Lipsky BA. Complicated infections of skin and skin structures: When the infection is more than skin deep. J Antimicrob Chemother 2004; 53 (suppl): S37-50.
156. Chapnick EK, Abter EI. Necrotizing soft tissue infections. Infect Dis Clin North Am 1996; 10: 835-55.
157. Wilkinson D, Dooletter D. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg 2004; 139: 1339-45.
158. Dellinger RP. Post hoc analyses in sepsis trials: A formula for disappointment? Crit Care Med 1996; 24: 727-9.
159. Lin E, Lowry SF. Inflammatory cytokines n major surgery: A functional perspective. Intensive Care Med 1999; 25: 255-7.
160. Lonnemann G, Linnenweber S, Burg M, Koch KM. Transfer of endogenous pyrogens across artificial membranes? Kidney Int 1998; 66 (suppl): S43-6.
161. Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1977; 23: 288-96.
162. Willis C, Lybrand S, Bellamy N. Excitatory amino acid inhibitors for traumatic brain injury. Cochrane Database Syst Rev 2004; 1: CD003986.
163. Hlatky R, Furuya Y, Valadka AB, Goodman JC, Robertson CS. Comparison of microdialysate arginine and glutamate levels in severely head-injured patient. Acta Neurochir Suppl 2002; 81: 347-9.
164. Hlatky R, Valadka AB, Goodman JC, Contant CF, Robertson CS. Patterns of energy substrate during ischemia measured in the brain by microdialysis. J Neurotrauma 2004; 21: 894-906.
165. Coraim FI, Owen A, Trubel W, Kassal H, Widhalm K. Regulatory effect of neurotransmitter by hemofiltration in cardiogenic shock patients after open heart surgery. Contrib Nephrol 1991; 93: 90-3.
166. Humes HD, Weitzel WE, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, et al. Initial clinical results of the bio-artificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004; 66: 1578-88.